Cargando…

Prevalence of blood stream infections and associated factors among febrile neutropenic cancer patients on chemotherapy at Ocean Road Cancer Institute, Tanzania

BACKGROUND: Febrile Neutropenia (FN) caused by bacteria in cancer patients is associated with poor prognosis. The aim of this study was to determine the prevalence of FN and associated factors among cancer patients on chemotherapy at Ocean Road Cancer Institute (ORCI), Tanzania. METHODS: A cross-sec...

Descripción completa

Detalles Bibliográficos
Autores principales: Safari, Lambert C., Mloka, Doreen, Minzi, Omary, Dharsee, Nazima J., Reuben, Rabson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510178/
https://www.ncbi.nlm.nih.gov/pubmed/37730617
http://dx.doi.org/10.1186/s13027-023-00533-8
_version_ 1785107910281396224
author Safari, Lambert C.
Mloka, Doreen
Minzi, Omary
Dharsee, Nazima J.
Reuben, Rabson
author_facet Safari, Lambert C.
Mloka, Doreen
Minzi, Omary
Dharsee, Nazima J.
Reuben, Rabson
author_sort Safari, Lambert C.
collection PubMed
description BACKGROUND: Febrile Neutropenia (FN) caused by bacteria in cancer patients is associated with poor prognosis. The aim of this study was to determine the prevalence of FN and associated factors among cancer patients on chemotherapy at Ocean Road Cancer Institute (ORCI), Tanzania. METHODS: A cross-sectional study was conducted from June to September 2019. Study participants were conveniently recruited. A desk review of participants medical records was performed. Standard microbiological procedures used to culture and identify the bacterial isolates from the positive blood cultures of participants that presented with FN. Kirby-Bauer disc diffusion was used to perform the antibiotics susceptibility testing. SPSS version 20.0 and MS Excel were used in data entry and analysis. Chi-Square was used as a measure of association between various factors and neutropenia. P-value less than 0.05 was considered statistically significant. RESULTS: A total 213 participants were enrolled. Of these 76.1% were female. Most of the participants came from the Coast region. Majority of participants presented with breast Cancer (36.2%) and GIT (20.2%). The prevalence of FN and bacteremia was 5.6% and 35.3% respectively. Staphylococcus Aureus (60%) and Coagulase-Negative Staphylococci (40%) were the main isolates. Of the 6 isolates tested most were resistant to Co-Trimoxazole 4/6 (66.7%) and Doxycycline 3/6 (50%). FN was positively associated with chemotherapy regimen (P = 0.0001), platelets count (P = 0.0001) and use of G-CSF (P = 0.0001). CONCLUSION: The prevalence of FN among the cancer patients on chemotherapy in Tanzania is low but associated with drug-resistant bacteria.
format Online
Article
Text
id pubmed-10510178
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105101782023-09-21 Prevalence of blood stream infections and associated factors among febrile neutropenic cancer patients on chemotherapy at Ocean Road Cancer Institute, Tanzania Safari, Lambert C. Mloka, Doreen Minzi, Omary Dharsee, Nazima J. Reuben, Rabson Infect Agent Cancer Research BACKGROUND: Febrile Neutropenia (FN) caused by bacteria in cancer patients is associated with poor prognosis. The aim of this study was to determine the prevalence of FN and associated factors among cancer patients on chemotherapy at Ocean Road Cancer Institute (ORCI), Tanzania. METHODS: A cross-sectional study was conducted from June to September 2019. Study participants were conveniently recruited. A desk review of participants medical records was performed. Standard microbiological procedures used to culture and identify the bacterial isolates from the positive blood cultures of participants that presented with FN. Kirby-Bauer disc diffusion was used to perform the antibiotics susceptibility testing. SPSS version 20.0 and MS Excel were used in data entry and analysis. Chi-Square was used as a measure of association between various factors and neutropenia. P-value less than 0.05 was considered statistically significant. RESULTS: A total 213 participants were enrolled. Of these 76.1% were female. Most of the participants came from the Coast region. Majority of participants presented with breast Cancer (36.2%) and GIT (20.2%). The prevalence of FN and bacteremia was 5.6% and 35.3% respectively. Staphylococcus Aureus (60%) and Coagulase-Negative Staphylococci (40%) were the main isolates. Of the 6 isolates tested most were resistant to Co-Trimoxazole 4/6 (66.7%) and Doxycycline 3/6 (50%). FN was positively associated with chemotherapy regimen (P = 0.0001), platelets count (P = 0.0001) and use of G-CSF (P = 0.0001). CONCLUSION: The prevalence of FN among the cancer patients on chemotherapy in Tanzania is low but associated with drug-resistant bacteria. BioMed Central 2023-09-20 /pmc/articles/PMC10510178/ /pubmed/37730617 http://dx.doi.org/10.1186/s13027-023-00533-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Safari, Lambert C.
Mloka, Doreen
Minzi, Omary
Dharsee, Nazima J.
Reuben, Rabson
Prevalence of blood stream infections and associated factors among febrile neutropenic cancer patients on chemotherapy at Ocean Road Cancer Institute, Tanzania
title Prevalence of blood stream infections and associated factors among febrile neutropenic cancer patients on chemotherapy at Ocean Road Cancer Institute, Tanzania
title_full Prevalence of blood stream infections and associated factors among febrile neutropenic cancer patients on chemotherapy at Ocean Road Cancer Institute, Tanzania
title_fullStr Prevalence of blood stream infections and associated factors among febrile neutropenic cancer patients on chemotherapy at Ocean Road Cancer Institute, Tanzania
title_full_unstemmed Prevalence of blood stream infections and associated factors among febrile neutropenic cancer patients on chemotherapy at Ocean Road Cancer Institute, Tanzania
title_short Prevalence of blood stream infections and associated factors among febrile neutropenic cancer patients on chemotherapy at Ocean Road Cancer Institute, Tanzania
title_sort prevalence of blood stream infections and associated factors among febrile neutropenic cancer patients on chemotherapy at ocean road cancer institute, tanzania
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510178/
https://www.ncbi.nlm.nih.gov/pubmed/37730617
http://dx.doi.org/10.1186/s13027-023-00533-8
work_keys_str_mv AT safarilambertc prevalenceofbloodstreaminfectionsandassociatedfactorsamongfebrileneutropeniccancerpatientsonchemotherapyatoceanroadcancerinstitutetanzania
AT mlokadoreen prevalenceofbloodstreaminfectionsandassociatedfactorsamongfebrileneutropeniccancerpatientsonchemotherapyatoceanroadcancerinstitutetanzania
AT minziomary prevalenceofbloodstreaminfectionsandassociatedfactorsamongfebrileneutropeniccancerpatientsonchemotherapyatoceanroadcancerinstitutetanzania
AT dharseenazimaj prevalenceofbloodstreaminfectionsandassociatedfactorsamongfebrileneutropeniccancerpatientsonchemotherapyatoceanroadcancerinstitutetanzania
AT reubenrabson prevalenceofbloodstreaminfectionsandassociatedfactorsamongfebrileneutropeniccancerpatientsonchemotherapyatoceanroadcancerinstitutetanzania